Business ❯ Startups ❯ Venture Capital

AI Companies

Public Benefit Corporations UK Government Nvidia Investment Strategies Market Trends DeepSeek Legal Challenges

Isomorphic Labs Raises $2.1 Billion to Scale AI Drug Design

Investors are backing a push to prove AI-designed drugs in human trials by late 2026.

UK Launches £500 Million Sovereign AI Unit to Scale Homegrown Startups